Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DRβ1⁎0402 tetramers
Christian Veldman(Friedrich-Alexander-Universität Erlangen-Nürnberg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Rüdiger Eming(Philipps University of Marburg), Sonja Wolff‐Franke(Universitätsklinikum Gießen und Marburg), Grete Sønderstrup(Stanford University), William W. Kwok(Virginia Mason Medical Center)
Cited by 17
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247